Which has higher valuation and earnings, BVS or MOBI?

Bioventus has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventus $568.09M 1.94 $22.73M $0.77 17.05 Mobia Medical $32.04M 9.54 -$46.50M -$20.18 N/A

Which has stronger valuation & earnings, MOBI or AORT?

Artivion has higher revenue and earnings than Mobia Medical. Artivion is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mobia Medical $32.04M 9.54 -$46.50M -$20.18 N/A Artivion $441.33M 2.46 $9.77M -$0.07 N/A

Which has higher valuation and earnings, MOBI or IRMD?

iRadimed has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mobia Medical $32.04M 9.54 -$46.50M -$20.18 N/A iRadimed $83.81M 13.03 $22.48M $1.79 47.71

Is ENOV or MOBI more profitable?

Mobia Medical has a net margin of 0.00% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Mobia Medical's return on equity. Company Net Margins Return on Equity Return on Assets Enovis -47.96% 12.03% 4.91% Mobia Medical N/A N/A N/A

Mobia Medical (MOBI) Competitors

$9.18 +0.15 (+1.66%)

As of 10/2/2026 04:00 PM Eastern

Compare

MOBI vs. BVS, AORT, IRMD, TNDM, and ENOV

Should you buy Mobia Medical stock or one of its competitors? Mobia Medical's main competitors and comparable companies include Bioventus (BVS), Artivion (AORT), iRadimed (IRMD), Tandem Diabetes Care (TNDM), and Enovis (ENOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Mobia Medical compare to Bioventus?

Bioventus (NASDAQ:BVS) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

62.9% of Bioventus shares are held by institutional investors. 33.5% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bioventus currently has a consensus target price of $16.80, indicating a potential upside of 27.95%. Mobia Medical has a consensus target price of $20.75, indicating a potential upside of 126.03%. Given Mobia Medical's higher probable upside, analysts plainly believe Mobia Medical is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioventus	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Bioventus has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventus	$568.09M	1.94	$22.73M	$0.77	17.05
Mobia Medical	$32.04M	9.54	-$46.50M	-$20.18	N/A

In the previous week, Bioventus had 3 more articles in the media than Mobia Medical. MarketBeat recorded 3 mentions for Bioventus and 0 mentions for Mobia Medical. Bioventus' average media sentiment score of 0.34 beat Mobia Medical's score of 0.00 indicating that Bioventus is being referred to more favorably in the media.

Company	Overall Sentiment
Bioventus	Neutral
Mobia Medical	Neutral

Bioventus has a net margin of 9.36% compared to Mobia Medical's net margin of 0.00%. Bioventus' return on equity of 28.08% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventus	9.36%	28.08%	9.82%
Mobia Medical	N/A	N/A	N/A

Summary

Bioventus beats Mobia Medical on 12 of the 14 factors compared between the two stocks.

How does Mobia Medical compare to Artivion?

Mobia Medical (NASDAQ:MOBI) and Artivion (NYSE:AORT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

In the previous week, Artivion had 1 more articles in the media than Mobia Medical. MarketBeat recorded 1 mentions for Artivion and 0 mentions for Mobia Medical. Artivion's average media sentiment score of 0.90 beat Mobia Medical's score of 0.00 indicating that Artivion is being referred to more favorably in the news media.

Company	Overall Sentiment
Mobia Medical	Neutral
Artivion	Positive

Mobia Medical presently has a consensus price target of $20.75, indicating a potential upside of 126.03%. Artivion has a consensus price target of $44.83, indicating a potential upside of 101.50%. Given Mobia Medical's higher probable upside, analysts clearly believe Mobia Medical is more favorable than Artivion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Artivion	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Artivion has higher revenue and earnings than Mobia Medical. Artivion is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	9.54	-$46.50M	-$20.18	N/A
Artivion	$441.33M	2.46	$9.77M	-$0.07	N/A

Mobia Medical has a net margin of 0.00% compared to Artivion's net margin of -0.67%. Artivion's return on equity of 6.07% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Artivion	-0.67%	6.07%	2.93%

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Artivion beats Mobia Medical on 11 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to iRadimed?

Mobia Medical (NASDAQ:MOBI) and iRadimed (NASDAQ:IRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

iRadimed has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	9.54	-$46.50M	-$20.18	N/A
iRadimed	$83.81M	13.03	$22.48M	$1.79	47.71

92.3% of iRadimed shares are held by institutional investors. 34.6% of iRadimed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, iRadimed had 3 more articles in the media than Mobia Medical. MarketBeat recorded 3 mentions for iRadimed and 0 mentions for Mobia Medical. iRadimed's average media sentiment score of 1.04 beat Mobia Medical's score of 0.00 indicating that iRadimed is being referred to more favorably in the news media.

Company	Overall Sentiment
Mobia Medical	Neutral
iRadimed	Positive

iRadimed has a net margin of 26.70% compared to Mobia Medical's net margin of 0.00%. iRadimed's return on equity of 23.45% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
iRadimed	26.70%	23.45%	20.36%

Mobia Medical currently has a consensus target price of $20.75, indicating a potential upside of 126.03%. iRadimed has a consensus target price of $120.00, indicating a potential upside of 40.52%. Given Mobia Medical's higher possible upside, equities analysts plainly believe Mobia Medical is more favorable than iRadimed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
iRadimed	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

iRadimed beats Mobia Medical on 14 of the 16 factors compared between the two stocks.

How does Mobia Medical compare to Tandem Diabetes Care?

Mobia Medical (NASDAQ:MOBI) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

In the previous week, Tandem Diabetes Care had 9 more articles in the media than Mobia Medical. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 0 mentions for Mobia Medical. Tandem Diabetes Care's average media sentiment score of 0.57 beat Mobia Medical's score of 0.00 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company	Overall Sentiment
Mobia Medical	Neutral
Tandem Diabetes Care	Positive

Mobia Medical has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -6.08%. Mobia Medical's return on equity of 0.00% beat Tandem Diabetes Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Tandem Diabetes Care	-6.08%	-45.97%	-6.23%

Mobia Medical has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	9.54	-$46.50M	-$20.18	N/A
Tandem Diabetes Care	$1.01B	1.13	-$204.71M	-$0.93	N/A

Mobia Medical currently has a consensus target price of $20.75, indicating a potential upside of 126.03%. Tandem Diabetes Care has a consensus target price of $29.13, indicating a potential upside of 76.56%. Given Mobia Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Mobia Medical is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.48

Summary

Mobia Medical beats Tandem Diabetes Care on 8 of the 14 factors compared between the two stocks.

How does Mobia Medical compare to Enovis?

Enovis (NYSE:ENOV) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Mobia Medical has a net margin of 0.00% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
Mobia Medical	N/A	N/A	N/A

98.5% of Enovis shares are held by institutional investors. 2.9% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Mobia Medical has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25B	0.45	-$1.18B	-$19.26	N/A
Mobia Medical	$32.04M	9.54	-$46.50M	-$20.18	N/A

In the previous week, Enovis had 2 more articles in the media than Mobia Medical. MarketBeat recorded 2 mentions for Enovis and 0 mentions for Mobia Medical. Enovis' average media sentiment score of 0.81 beat Mobia Medical's score of 0.00 indicating that Enovis is being referred to more favorably in the media.

Company	Overall Sentiment
Enovis	Positive
Mobia Medical	Neutral

Enovis presently has a consensus price target of $40.38, suggesting a potential upside of 127.81%. Mobia Medical has a consensus price target of $20.75, suggesting a potential upside of 126.03%. Given Enovis' stronger consensus rating and higher probable upside, analysts clearly believe Enovis is more favorable than Mobia Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Enovis beats Mobia Medical on 11 of the 15 factors compared between the two stocks.

Get Mobia Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MOBI vs. The Competition

Export

Metric	Mobia Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$305.61M	$5.48B	$7.15B	$13.28B
Dividend Yield	N/A	1.81%	2.54%	17.33%
P/E Ratio	-0.45	25.42	274.71	26.04
Price / Sales	9.54	67.70	656.46	105.13
Price / Cash	N/A	32.27	78.87	52.62
Price / Book	N/A	5.73	10.93	6.31
Net Income	-$46.50M	$152.68M	$3.51B	$362.16M
7 Day Performance	1.32%	-1.71%	-2.00%	-1.66%
1 Month Performance	-21.07%	-4.87%	-6.19%	-4.68%
1 Year Performance	N/A	1.30%	8.03%	1.57%

Mobia Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MOBI Mobia Medical	3.2565 of 5 stars	$9.18 +1.7%	$20.75 +126.0%	N/A	$305.61M	$32.04M	N/A	167	Positive News
BVS Bioventus	3.8004 of 5 stars	$13.81 +2.1%	$16.80 +21.7%	+87.0%	$1.16B	$568.09M	17.94	950	News Coverage
AORT Artivion	2.8625 of 5 stars	$22.70 -1.4%	$44.83 +97.5%	-45.8%	$1.10B	$441.33M	N/A	1,800
IRMD iRadimed	3.097 of 5 stars	$85.76 +0.7%	$120.00 +39.9%	+19.9%	$1.10B	$83.81M	47.91	166	Positive News Analyst Downgrade
TNDM Tandem Diabetes Care	2.5416 of 5 stars	$15.72 +3.3%	$29.18 +85.7%	+12.2%	$1.09B	$1.01B	N/A	2,500	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MOBI) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mobia Medical (MOBI) Competitors

MOBI vs. BVS, AORT, IRMD, TNDM, and ENOV

How does Mobia Medical compare to Bioventus?

Summary

How does Mobia Medical compare to Artivion?

Summary

How does Mobia Medical compare to iRadimed?

Summary

How does Mobia Medical compare to Tandem Diabetes Care?

Summary

How does Mobia Medical compare to Enovis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOBI vs. The Competition

Mobia Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mobia Medical (MOBI) Competitors

MOBI vs. BVS, AORT, IRMD, TNDM, and ENOV

How does Mobia Medical compare to Bioventus?

Do insiders and institutionals believe in BVS or MOBI?

Do analysts rate BVS or MOBI?

Which has higher valuation and earnings, BVS or MOBI?

Does the media prefer BVS or MOBI?

Is BVS or MOBI more profitable?

Summary

How does Mobia Medical compare to Artivion?

Does the media favor MOBI or AORT?

Do analysts prefer MOBI or AORT?

Which has stronger valuation & earnings, MOBI or AORT?

Is MOBI or AORT more profitable?

Do insiders & institutionals hold more shares of MOBI or AORT?

Summary

How does Mobia Medical compare to iRadimed?

Which has higher valuation and earnings, MOBI or IRMD?

Do insiders and institutionals hold more shares of MOBI or IRMD?

Does the media prefer MOBI or IRMD?

Is MOBI or IRMD more profitable?

Do analysts prefer MOBI or IRMD?

Summary

How does Mobia Medical compare to Tandem Diabetes Care?

Does the media favor MOBI or TNDM?

Is MOBI or TNDM more profitable?

Which has higher earnings & valuation, MOBI or TNDM?

Do analysts recommend MOBI or TNDM?

Summary

How does Mobia Medical compare to Enovis?

Is ENOV or MOBI more profitable?

Do insiders and institutionals have more ownership in ENOV or MOBI?

Which has better earnings and valuation, ENOV or MOBI?

Does the media favor ENOV or MOBI?

Do analysts recommend ENOV or MOBI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOBI vs. The Competition

Mobia Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools